Translocation 4; 11 in acute lymphoblastic leukemia: clinical characteristics and prognostic significance.

Blood (Impact Factor: 9.78). 02/1982; 59(1):96-9.
Source: PubMed

ABSTRACT Banded bone marrow chromosome analyses have been done on 83 unselected patients with acute lymphoblastic leukemia (ALL). Seven patients, all with non-T, non-B ALL, had a translocation involving the long arms of chromosomes 4 and 11. Five of these patients, 4 children and 1 adult, were first studied at diagnosis, and the t(4;11) (q21;q23) was the only karyotypic abnormality. All 5 presented with a marked leukocytosis (greater than 150 X 10(9)/liter). Four of these 5 patients achieved a complete remission following the same intensive treatment regimen; however, remission duration and survival were very short (medians 2.5 and 8 mo, respectively). The fifth patient is currently receiving induction chemotherapy. The remaining 2 patients, both adults, were studied in relapse only, and had other karyotypic abnormalities in addition to the t(4;11). One of these relapse patients was a female whose clinical presentation and course were similar to those above. The last patient was a male who presented with a leukocyte count of 7 X 10(9)/liter and maintained an initial complete remission for 37 mo. Our data suggest that patients who have a t(4;11) (q21;q23) at the time of diagnosis of ALL have a poor prognosis with conventional therapy and require a new therapeutic approach.

  • [Show abstract] [Hide abstract]
    ABSTRACT: . We report a case of acute leukaemia with the t(4;l 1) chromosomal translocation which, at initial diagnosis, had L-l lymphoblasts that were positive for terminal deoxynucleotidyl transferase (TdT) and HLA-DR but negative for myeloid cytochemical markers. At last relapse the patient had mostly monocytoid blasts which were now TdT negative but were positive for HLA-DR, weakly positive for Sudan Black B (SB), periodic acid Schiffs (PAS), naphthol AS-D acetate esterase (NSE), chloroacetate esterase (CAE) and negative for acid phosphatase (AP) and nitroblue tetrazolium (NBT) reduction. Treatment with 12-o-tetradecanoylphorbol-13-acetate (TPA) in vitro induced differentiation to macrophage-Iike cells that were strongly positive for SB, PAS, NSE, AP, CAE and NBT reduction, indicating a latent monocyte-like phenotype. Thus the leukaemic cell clone or a precurser clone with the t(4;l 1) translocation manifested a lymphoid phenotype at initial diagnosis and a monocytoid phenotype at relapse. Immunoglobulin gene analysis of the monocytoid relapse blasts revealed rearrangements of the heavy chain gene alleles and germline light chain genes. Thus, the leukaemia clone with the t(4;ll) chromosomal translocation could be a bipotential cell with heavy chain gene rearrangements occurring in a primitive cell which may retain the ability to differentiate along the myeloid-monocytoid lineage in response to the appropriate stimulus. Alternatively, these characteristics may result from a transformation associated event.
    British Journal of Haematology 06/2008; 63(2):321-329. DOI:10.1111/j.1365-2141.1986.tb05555.x · 4.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Karyotypic and immunophenotypic changes during clonal evolution were studied in 5 B-lineage and 5 T-lineage acute lymphoblastic leukemia (ALL) patients using leukemic progenitor cell assays in combination with cytogenetic and immunophenotypic analyses. Cytogenetic studies demonstrated a clonal chromosomal abnormality in 9 of 10 cases analyzed. The use of leukemic progenitor cell assay system revealed a distinct cytogenetic pattern of clonal evolution in 4 of the 7 patients who experienced leukemic relapses. It also made possible the identification of an abnormal clone in 2 patients in whom no analyzable metaphases were found in fresh marrow blasts. The evidence uniquely indicates that, in ALL 1) leukemic progenitor cell assays combined with fresh marrow cytogenetic and immunophenotypic analyses help clarify the sequence of cytogenetic and immunophenotypic changes during clonal evolution, 2:) cytogenetic changes may occur independent of immunophenotypic changes during clonal evolution, 3) immunologically distinct subclones may exist in a cytogenetically uniform blast population, and 4) normal diploid cells in leukemic bone marrow samples may occasionally represent clonal populations of cytogenetically “normal” leukemic blasts with submicroscopic genetic alterations. To our knowledge, this study represents the first application of leukemic progenitor cell assays in the cytogenetic analyses of ALL blasts. The described methodology can be used for further elucidation of clonal evolution in ALL as well as for more detailed analyses of individual leukemic clones derived from ALL patients.
    Leukemia and Lymphoma 06/1990; 2(1):1-16. DOI:10.3109/10428199009042510 · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Forty-eight Japanese infants with acute lymphoid leukemia (ALL) (n = 24) and acute nonlymphoid leukemia (ANLL) (n = 24) were analyzed on the basis of clinical and laboratory data. Morphologically, 20 of the 24 infants with ALL were of the FAB L1 type, and 20 of the 24 infants with ANLL were of the M4 or M5 type. Markedly enlarged liver and spleen, and hyperleukocytosis (more than 50,000/μl) were seen in 9, 12, and 14 infants with ALL and 10, 11, and 10 infants with ANLL, respectively. Initial CNS leukemia was evident in 2 infants. Chromosome studies of the leukemic cells showed abnormal karyotypes in 9 of the 21 infants with ALL and 19 of the 22 infants with ANLL, consisting mainly of translocation 11, 12, and inversion 16. By surface marker analysis, only 7 of the 22 infants with ALL (32%) were diagnosed as having common ALL (HLA-DR+, CD19+, CD10+). Of the 15 infants with ANLL, 12 and 5 infants also showed reactivity to HLA-DR and CD19, respectively. All of the 5 ANLL infants with lymphoid markers showed different leukemic cell features at the time of relapse. Twelve of the 19 infants with ALL (63%) who achieved a complete remission relapsed within the first 2 years; 8 of the 21 with ANLL (38%) relapsed within the first year. Analysis of event-free survival shows that the ALL infants with hyperleukocytosis have a poorer prognosis than those without hyperleukocytosis (p < 0.05). Infant leukemia originates in a multipotent cell with lymphoid and myeloid features, and intensive multiagent chemotherapy is necessary for the treatment of infants with acute leukemia.
    Medical and Pediatric Oncology 01/1991; 19(1). DOI:10.1002/mpo.2950190106